Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8001616rdf:typepubmed:Citationlld:pubmed
pubmed-article:8001616lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8001616lifeskim:mentionsumls-concept:C2926606lld:lifeskim
pubmed-article:8001616lifeskim:mentionsumls-concept:C0014544lld:lifeskim
pubmed-article:8001616lifeskim:mentionsumls-concept:C0740279lld:lifeskim
pubmed-article:8001616lifeskim:mentionsumls-concept:C0031507lld:lifeskim
pubmed-article:8001616lifeskim:mentionsumls-concept:C2607943lld:lifeskim
pubmed-article:8001616lifeskim:mentionsumls-concept:C0024485lld:lifeskim
pubmed-article:8001616lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:8001616pubmed:dateCreated1995-1-26lld:pubmed
pubmed-article:8001616pubmed:abstractTextMild overdosage of phenytoin produces reversible cerebellar symptoms (nystagmus, double vision, dysarthria and ataxia). Several case reports suggest that relatively mild and relatively short intoxication can lead to cerebellar degeneration. We observed 11 patients who had episodes of abnormally increased serum levels, most of which developed clinical signs of cerebellar dysfunction. All of these patients were examined with a 1.5-tesla whole-body system (Magnetom, Siemens). Five patients had normal cerebellar structures, although 3 of them had a history of clinical intoxication and all had at least one episode of increased serum level of diphenylhydantoin. The remaining 5 had moderate to severe cerebellar atrophy. Two of them never experienced signs of clinical intoxication. There was no correlation between degree of atrophy and severity of clinical symptoms and elevation of serum DPH levels. There was no correlation between cerebellar atrophy, duration of epilepsy and frequency of seizures.lld:pubmed
pubmed-article:8001616pubmed:languageenglld:pubmed
pubmed-article:8001616pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8001616pubmed:citationSubsetIMlld:pubmed
pubmed-article:8001616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8001616pubmed:statusMEDLINElld:pubmed
pubmed-article:8001616pubmed:issn0014-3022lld:pubmed
pubmed-article:8001616pubmed:authorpubmed-author:BauerGGlld:pubmed
pubmed-article:8001616pubmed:authorpubmed-author:AichnerFFlld:pubmed
pubmed-article:8001616pubmed:authorpubmed-author:LuefGGlld:pubmed
pubmed-article:8001616pubmed:authorpubmed-author:BirbamerGGlld:pubmed
pubmed-article:8001616pubmed:authorpubmed-author:ChemelloGGlld:pubmed
pubmed-article:8001616pubmed:issnTypePrintlld:pubmed
pubmed-article:8001616pubmed:volume34 Suppl 1lld:pubmed
pubmed-article:8001616pubmed:ownerNLMlld:pubmed
pubmed-article:8001616pubmed:authorsCompleteYlld:pubmed
pubmed-article:8001616pubmed:pagination79-81lld:pubmed
pubmed-article:8001616pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8001616pubmed:meshHeadingpubmed-meshheading:8001616-...lld:pubmed
pubmed-article:8001616pubmed:meshHeadingpubmed-meshheading:8001616-...lld:pubmed
pubmed-article:8001616pubmed:meshHeadingpubmed-meshheading:8001616-...lld:pubmed
pubmed-article:8001616pubmed:meshHeadingpubmed-meshheading:8001616-...lld:pubmed
pubmed-article:8001616pubmed:meshHeadingpubmed-meshheading:8001616-...lld:pubmed
pubmed-article:8001616pubmed:meshHeadingpubmed-meshheading:8001616-...lld:pubmed
pubmed-article:8001616pubmed:meshHeadingpubmed-meshheading:8001616-...lld:pubmed
pubmed-article:8001616pubmed:meshHeadingpubmed-meshheading:8001616-...lld:pubmed
pubmed-article:8001616pubmed:meshHeadingpubmed-meshheading:8001616-...lld:pubmed
pubmed-article:8001616pubmed:meshHeadingpubmed-meshheading:8001616-...lld:pubmed
pubmed-article:8001616pubmed:meshHeadingpubmed-meshheading:8001616-...lld:pubmed
pubmed-article:8001616pubmed:meshHeadingpubmed-meshheading:8001616-...lld:pubmed
pubmed-article:8001616pubmed:meshHeadingpubmed-meshheading:8001616-...lld:pubmed
pubmed-article:8001616pubmed:meshHeadingpubmed-meshheading:8001616-...lld:pubmed
pubmed-article:8001616pubmed:year1994lld:pubmed
pubmed-article:8001616pubmed:articleTitlePhenytoin overdosage and cerebellar atrophy in epileptic patients: clinical and MRI findings.lld:pubmed
pubmed-article:8001616pubmed:affiliationDepartment of Neurology, University of Innsbruck, Austria.lld:pubmed
pubmed-article:8001616pubmed:publicationTypeJournal Articlelld:pubmed